Form 4: Precigen Director Converts RSUs to Common Stock

Precigen Director Steven Frank converted 71,839 restricted stock units into common stock, increasing his direct ownership.

Summary

• Steven Frank, a Director of Precigen, Inc. (PGEN), reported a change in beneficial ownership.
• On March 13, 2026, 71,839 Restricted Stock Units (RSUs) vested in full.
• These vested RSUs were converted into 71,839 shares of Precigen common stock.
• Following this transaction, Steven Frank beneficially owns 1,226,391 shares of common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting a routine equity compensation vesting and conversion, which increases a director's direct stake in the company.

Positives

• Director Steven Frank increased his direct beneficial ownership of Precigen common stock by 71,839 shares.
• The full vesting of 71,839 Restricted Stock Units (RSUs) indicates the fulfillment of equity compensation terms.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly conversions of equity awards, are common in the biotechnology and pharmaceutical sectors, reflecting standard executive compensation practices. This specific transaction does not indicate a significant shift in company strategy or market position but rather a routine vesting event.

Comparison to Industry Standards

• This is a standard equity compensation vesting and conversion event for a director, common across publicly traded companies, especially in the biotech sector, as part of long-term incentive plans. No specific comparable companies or projects are detailed in this Form 4.

Corporate Governance

Stakeholder Impact

• Shareholders: Director's increased direct ownership may be seen as a positive signal of alignment with shareholder interests.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Recommendation

This Form 4 filing details a routine vesting and conversion of Restricted Stock Units (RSUs) into common stock by a director. It does not present new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. It simply reflects a standard equity compensation event, increasing the director's direct stake, which is generally a neutral to slightly positive signal of alignment. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a 'buy' or 'sell' decision.

Keywords

Precigen, PGEN, Steven Frank, Director, Form 4, RSU, Restricted Stock Units, Common Stock, Insider Transaction, Equity Compensation, 10b5-1